[New Date] BOPA’s Celebrate Pride Month Webinar

Due to an unforeseeable technical issue, we have had to reschedule our Celebrate Pride Month Webinar.

The new date is Thursday 13th June 2024 at 1pm BST.

If you have registered for the webinar on the original date, you don’t have to register again. A new Zoom link will be re-sent to you.

We hope to see you again on Thursday 13th.

 

Best Wishes,

BOPA EDI Subcommittee

====================================================================

 

To celebrate Pride Month, BOPA is organising a webinar on clinical considerations for the safe and effective prescribing for trans individuals living with cancer. This event will be amplified by the European Cancer Organisation who members will be able to join this event.

Date: Thursday, 13th June 2024 ; 13:00-14:00 UK time (14:00-15:00 CET)

 

Speakers:

Stewart O’Callaghan, Founder and CEO, OUTPATIENTs

Mariachiara D’Elia, Member of BOPA EDI sub-committee; pharmacist at Royal Marsden NHS Foundation Trust

Shereen Nabhani-Gebara, BOPA vice-chair and chair of EDI sub-committee; Associate professor of Oncology at Kingston University

 

In this session, the speakers will discuss the newly launched guide that supports healthcare professionals to deliver an inclusive consultation while considering pharmacokinetic, pharmacodynamic parameters that might influence prescribing decisions.

This guide is the result of a collaboration between OUTPATIENTs and BOPA.

 

Click here for more info.

 

This webinar is FREE for all BOPA members and associates.
BOPA members and associate click HERE to register
Click here to join BOPA

Latest News

By BOPA Committee on 22nd July 2024

REMINDER – 2024 Elections to the BOPA Executive Committee: Call for nomination of members

BOPA is looking for new Executive Committee members who are dedicated to furthering the association’s aims and who are willing, and able, to spend time helping run the organisation. Those…

Read article
By BOPA Committee on 12th July 2024

TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients

BOPA is delighted to announce the publication of TRANScribing: Clinical considerations for safe and inclusive prescribing for transgender and non-binary patients in collaboration with OUTpatients. It is estimated that one…

Read article
By BOPA Committee on 11th July 2024

Round Table Discussion at #BOPA2024

  As an exciting addition to the 2024 conference, we invite you all to participate in one of our interactive sessions on the Sunday morning. We have a lineup of…

Read article
By BOPA Committee on 10th July 2024

APTUK Position Statement for DHSC PGD Update

The Association of Pharmacy Technicians UK (APTUK), as the professional leadership body for pharmacy technicians, welcome the positive outcome of the DHSC consultation supporting the enabling of registered pharmacy technicians…

Read article